REFERENCES
1. Dehghani Firouzabadi M, Dehghani Firouzabadi F, Goudarzi S,
Jahandideh H, Roomiani M. Has the chief complaint of patients with
COVID-19 disease changed over time? Medical Hypotheses.2020;144:109974.
2. Firouzabadi FD, Firouzabadi MD, Ghalehbaghi B, Jahandideh H, Roomiani
M, Goudarzi S. Have the symptoms of patients with COVID-19 changed over
time during hospitalization? Medical Hypotheses. 2020;143:110067.
3. Dehghani Firouzabadi F DFM, Ghalehbaghi B, Jahandideh H, Roomiani M,
Goudarzi S, Moosaie F, Chi G. What is the difference between the first
and second COVID-19 outbreak in Iran? International Journal of
Cardiovascular Diseases & Diagnosis. 2020;In Press.
4. Qin C, Zhou L, Hu Z, et al. Dysregulation of Immune Response in
Patients With Coronavirus 2019 (COVID-19) in Wuhan, China.Clinical Infectious Diseases. 2020.
5. Betoule A, Martinet C, Gasperini G, et al. Diagnosis of venous and
arterial thromboembolic events in COVID-19 virus-infected patients.J Thromb Thrombolysis. 2020;50(2):302-304.
6. Dashraath P, Wong JLJ, Lim MXK, et al. Coronavirus disease 2019
(COVID-19) pandemic and pregnancy. American Journal of Obstetrics
and Gynecology. 2020;222(6):521-531.
7. Cui S, Chen S, Li X, Liu S, Wang F. Prevalence of venous
thromboembolism in patients with severe novel coronavirus pneumonia.
(1538-7836 (Electronic)).
8. Klok FA, Kruip MJHA, van der Meer NJM, et al. Incidence of thrombotic
complications in critically ill ICU patients with COVID-19. Thromb
Res. 2020;191:145-147.
9. Iba T, Levy JH, Connors JM, Warkentin TE, Thachil J, Levi M. The
unique characteristics of COVID-19 coagulopathy. Critical Care.2020;24(1):360.
10. Zhou F, Yu T, Du R, et al. Clinical course and risk factors for
mortality of adult inpatients with COVID-19 in Wuhan, China: a
retrospective cohort study. The Lancet.2020;395(10229):1054-1062.
11. Dehghani Firouzabadi M, Goudarzi S, Dehghani Firouzabadi F, Moosaie
F. Complete heart block and an itching rash in a patient with COVID-19.Caspian Journal of Internal Medicine. 2020.
12. Tang N, Bai H, Chen X, Gong J, Li D, Sun Z. Anticoagulant treatment
is associated with decreased mortality in severe coronavirus disease
2019 patients with coagulopathy. (1538-7836 (Electronic)).
13. Whyte CS, Morrow GB, Mitchell JL, Chowdary P, Mutch NJ. Fibrinolytic
abnormalities in acute respiratory distress syndrome (ARDS) and
versatility of thrombolytic drugs to treat COVID-19. Journal of
Thrombosis and Haemostasis. 2020;18(7):1548-1555.
14. Martinelli I, Ferrazzi E, Ciavarella A, et al. Pulmonary embolism in
a young pregnant woman with COVID-19. Thromb Res. 2020;191:36-37.
15. Di Mascio D, Khalil A, G S. Outcome of Coronavirus spectrum
infections (SARS, MERS, COVID 1 -19) during pregnancy: a systematic
review and meta-analysis. Am J Obstet Gynecol 2020;2(2):100-107.